期刊文献+
共找到931篇文章
< 1 2 47 >
每页显示 20 50 100
Research Survey of Animal Model of Hepatic Fibro-sis Integrated with Western Medicine Diseases and Traditional Chinese Medicine^TCM~)Syndrome 被引量:1
1
作者 Peng Yue Yao Le +3 位作者 Zhao Tiejian Duan Xuelin Wei Yanfei Li Guiyu 《Animal Husbandry and Feed Science》 CAS 2017年第1期19-23,36,共6页
Although the animal models of hepatic fibrosis developed by former researchers have pathological changes of hepatic fibrosis, they do not include charac- teristics of important TCM syndromes such as stagnation of qi, ... Although the animal models of hepatic fibrosis developed by former researchers have pathological changes of hepatic fibrosis, they do not include charac- teristics of important TCM syndromes such as stagnation of qi, deficiency of qi, liver depression, phlegm-dampness and blood stasis because of single-factor model- ing. Animal models of hepatic fibrosis and animal models integrated disease and syndrome were reviewed, and several new types of integrated disease and syndrome animal models constructed by multiple-factor modeling method were evaluated, under the guidance of etiological theory of TCM. This kind of hepatic fibrosis model animals has dual characteristics of disease and syndrome. It is consistent with pathological characteristics of hepatic fibrosis in western medicine when replicating the basic characteristics accorded with TCM syndrome. Thus, the pathogenesis and pathogenic process of clinical disease and syndrome formation is simulated more ac- curately, providing a new platform and pathway for studying hepatic fibrosis disease with integrated traditional Chinese and western medicine. 展开更多
关键词 Chinese traditional medicine combination of disease and syndrome Animal model
下载PDF
Creutzfeldt-Jakob disease presenting as Korsakoff syndrome caused by E196A mutation in PRNP gene:A case report
2
作者 Yong-Kang Zhang Jia-Rui Liu +3 位作者 Kang-Li Yin Yuan Zong Yu-Zhen Wang Ye-Min Cao 《World Journal of Clinical Cases》 SCIE 2023年第25期5982-5987,共6页
BACKGROUND Prion diseases are a group of degenerative nerve diseases that are caused by infectious prion proteins or gene mutations.In humans,prion diseases result from mutations in the prion protein gene(PRNP).Only a... BACKGROUND Prion diseases are a group of degenerative nerve diseases that are caused by infectious prion proteins or gene mutations.In humans,prion diseases result from mutations in the prion protein gene(PRNP).Only a limited number of cases involving a specific PRNP mutation at codon 196(E196A)have been reported.The coexistence of Korsakoff syndrome in patients with Creutzfeldt-Jakob disease(CJD)caused by E196A mutation has not been documented in the existing literature.CASE SUMMARY A 61-year-old Chinese man initially presented with Korsakoff syndrome,followed by rapid-onset dementia,visual hallucinations,akinetic mutism,myoclonus,and hyperthermia.The patient had no significant personal or familial medical history.Magnetic resonance imaging of the brain revealed extensive hyperintense signals in the cortex,while positron emission tomography/computed tomography showed a diffuse reduction in cerebral cortex metabolism.Routine biochemical and microorganism testing of the cerebrospinal fluid(CSF)yielded normal results.Tests for thyroid function,human immunodeficiency virus,syphilis,vitamin B1 and B12 levels,and autoimmune rheumatic disorders were normal.Blood and CSF tests for autoimmune encephalitis and autoantibody-associated paraneoplastic syndrome yielded negative results.A test for 14-3-3 protein in the CSF yielded negative results.Whole-genome sequencing revealed a diseasecausing mutation in PRNP.The patient succumbed to the illness 11 months after the initial symptom onset.CONCLUSION Korsakoff syndrome,typically associated with alcohol intoxication,also manifests in CJD patients.Individuals with CJD along with PRNP E196A mutation may present with Korsakoff syndrome. 展开更多
关键词 Prion disease Creutzfeldt-Jakob disease Korsakoff syndrome PRNP gene 14-3-3 proteins Case report
下载PDF
Combined liver-kidney transplantation for rare diseases
3
作者 Mladen Knotek Rafaela Novak +1 位作者 Alemka Jaklin-Kekez Anna Mrzljak 《World Journal of Hepatology》 CAS 2020年第10期722-737,共16页
Combined liver and kidney transplantation(CLKT)is indicated in patients with failure of both organs,or for the treatment of end-stage chronic kidney disease(ESKD)caused by a genetic defect in the liver.The aim of the ... Combined liver and kidney transplantation(CLKT)is indicated in patients with failure of both organs,or for the treatment of end-stage chronic kidney disease(ESKD)caused by a genetic defect in the liver.The aim of the present review is to provide the most up-to-date overview of the rare conditions as indications for CLKT.They are major indications for CLKT in children.However,in some of them(e.g.,atypical hemolytic uremic syndrome or primary hyperoxaluria),CLKT may be required in adults as well.Primary hyperoxaluria is divided into three types,of which type 1 and 2 lead to ESKD.CLKT has been proven effective in renal function replacement,at the same time preventing recurrence of the disease.Nephronophthisis is associated with liver fibrosis in 5%of cases and these patients are candidates for CLKT.In alpha 1-antitrypsin deficiency,hereditary C3 deficiency,lecithin cholesterol acyltransferase deficiency and glycogen storage diseases,glomerular or tubulointerstitial disease can lead to chronic kidney disease.Liver transplantation as a part of CLKT corrects underlying genetic and consequent metabolic abnormality.In atypical hemolytic uremic syndrome caused by mutations in the genes for factor H,successful CLKT has been reported in a small number of patients.However,for this indication,CLKT has been largely replaced by eculizumab,an anti-C5 antibody.CLKT has been well established to provide immune protection of the transplanted kidney against donor-specific antibodies against class I HLA,facilitating transplantation in a highly sensitized recipient. 展开更多
关键词 combined liver-kidney transplantation Methylmalonic aciduria Hereditary complement C3 deficiency Glycogen storage diseases Homozygous protein C deficiency Primary hyperoxaluria Atypical hemolytic uremic syndrome SENSITIZATION Donorspecific antibodies
下载PDF
Role of non-steroidal anti-inflammatory drugs on intestinal permeability and nonalcoholic fatty liver disease 被引量:12
4
作者 erika utzeri paolo usai 《World Journal of Gastroenterology》 SCIE CAS 2017年第22期3954-3963,共10页
The use of non-steroidal anti-inflammatory drugs(NSAIDs) is widespread worldwide thanks to their analgesic, anti-inflammatory and antipyretic effects. However, even more attention is placed upon the recurrence of dige... The use of non-steroidal anti-inflammatory drugs(NSAIDs) is widespread worldwide thanks to their analgesic, anti-inflammatory and antipyretic effects. However, even more attention is placed upon the recurrence of digestive system complications in the course of their use. Recent data suggests that the complications of the lower gastro-intestinal tract may be as frequent and severe as those of the upper tract. NSAIDs enteropathy is due to enterohepatic recycling of the drugs resulting in a prolonged and repeated exposure of the intestinal mucosa to the compound and its metabolites. Thus leading to so-called topical effects, which, in turn, lead to an impairment of the intestinal barrier. This process determines bacterial translocation and toxic substances of intestinal origin in the portal circulation, leading to an endotoxaemia. This condition could determine a liver inflammatory response and might promote the development of nonalcoholic steatohepatitis, mostly in patients with risk factors such as obesity, metabolic syndrome and a high fat diet, which may induce a small intestinal bacterial overgrowth and dysbiosis. This alteration of gut microbiota may contribute to nonalcoholic fatty liver disease and its related disorders in two ways: firstly causing a malfunction of the tight junctions that play a critical role in the increase of intestinal permeability, and then secondly leading to the development of insulin resistance, body weight gain, lipogenesis, fibrogenesis and hepatic oxidative stress. 展开更多
关键词 Non-steroidal anti-inflammatory drugs Intestinal barrier Intestinal permeability Non-steroidal anti-inflammatory drugs - enteropathy Nonalcoholic fatty liver disease Nonalcoholic steatohepatitis MICROBIOTA Metabolic syndrome Proton pump inhibitors ENDOTOXAEMIA
下载PDF
Disease-Syndrome Combination Clinical Study of Psoriasis:Present Status,Advantages,and Prospects 被引量:5
5
作者 卢传坚 喻靖杰 邓静文 《Chinese Journal of Integrative Medicine》 SCIE CAS 2012年第3期166-171,共6页
Psoriasis is an immune-abnormal,chronic,proliferative skin disease determined by polygenic inheritance and induced by a number of environmental factors.It causes worldwide concern because of its high-prevalence,harmfu... Psoriasis is an immune-abnormal,chronic,proliferative skin disease determined by polygenic inheritance and induced by a number of environmental factors.It causes worldwide concern because of its high-prevalence,harmful and incurable characteristics.Over the years,Chinese medicine(CM) treatment of psoriasis has accumulated a wealth of clinical experience.Disease-syndrome combination, which achieves more satisfactory clinical effect,is the basis to highlight the special CM advantages in treating psoriasis.In this paper,we review the advantages of treating psoriasis with the combination of disease and syndrome,analyze the prospects of research on treating psoriasis combining disease with syndrome.We also make a point that there are several key points for the clinical research of combination of disease and syndrome.It can be expected that carrying out clinical research on the combination of disease and syndrome will help improve the clinical efficacy of medical treatment of psoriasis,which will be the main direction of research in the future. 展开更多
关键词 PSORIASIS disease-syndrome combination Chinese medicine complementary and alternative medicine herbal medicine
原文传递
第二次中国中西医整合治疗幽门螺杆菌相关“病-证”共识
6
作者 胡伏莲 张声生 +1 位作者 张学智 唐旭东 《胃肠病学和肝病学杂志》 CAS 2024年第12期1581-1588,共8页
幽门螺杆菌防控一直是全球公共卫生领域的重要挑战。本共识是对2018年发布的《全国中西医整合治疗幽门螺杆菌相关“病-证”共识》进行的修订。幽门螺杆菌领域的中、西医专家依据最新的循证医学证据,结合临床诊疗经验,达成了《第二次中... 幽门螺杆菌防控一直是全球公共卫生领域的重要挑战。本共识是对2018年发布的《全国中西医整合治疗幽门螺杆菌相关“病-证”共识》进行的修订。幽门螺杆菌领域的中、西医专家依据最新的循证医学证据,结合临床诊疗经验,达成了《第二次中国中西医整合治疗幽门螺杆菌相关“病-证”共识》。本共识延续了整合医学理念,纳入了近年来的最新研究进展,充分分析了我国幽门螺杆菌感染面临的现状与挑战,针对难治性幽门螺杆菌感染提出中西医治疗方案,其遵从个体化治疗策略,体现中医辨证论治特色。本共识旨在规范幽门螺杆菌相关疾病的诊治决策,指导临床实践。 展开更多
关键词 幽门螺杆菌 整合医学 “病-证”结合 专家共识
下载PDF
基于《黄帝内经》病证结合思想探讨疾病循证病机-证治体系研究模式
7
作者 吴春丽 李可建 《山东中医药大学学报》 2024年第2期166-171,共6页
深度挖掘《黄帝内经》病证结合思想,《黄帝内经》首开辨病论治之先河,在此基础上,又将辨病与脏腑辨证、病因辨证、经络辨证及六经辨证有机结合,开启了病证结合思想的萌芽,为后世病机、证候、治则治法理论的发展奠定了坚实的理论基础。... 深度挖掘《黄帝内经》病证结合思想,《黄帝内经》首开辨病论治之先河,在此基础上,又将辨病与脏腑辨证、病因辨证、经络辨证及六经辨证有机结合,开启了病证结合思想的萌芽,为后世病机、证候、治则治法理论的发展奠定了坚实的理论基础。基于病机、证候、治法、方药之间的内在联系性与统一性,提出病证结合是循证病机-证治体系的立论基础,循证病机-证治体系以疾病为研究基础,以病机为核心要素,以临床疗效为评价标准,“基于疗效,评价病机”是构建疾病循证病机-证治体系的关键。在疾病循证病机-证治体系的构建过程中,借鉴循证医学系统评价的方法,通过“以方测证、验证病机”的方式,为循证病机-证治体系的构建提供思路。 展开更多
关键词 《黄帝内经》 辨病论治 病证结合 循证病机-证治体系 以方测证 验证病机
下载PDF
基于国医大师郭子光“人-症-病-证”体系探析慢性萎缩性胃炎临床辨治路径
8
作者 蒋萃 王昶鸿 +1 位作者 田茸 江泳 《成都中医药大学学报》 2024年第5期35-39,共5页
慢性萎缩性胃炎(Chronic Atrophic Gastritis,CAG)中常见的肠上皮化生、异型增生属于胃癌前状态。中医在逆转肠上皮化生及异型增生方面具有治疗优势。笔者系国医大师郭子光教授学术传承人,在郭师学术思想指导下,初步提出基于“人-症-病... 慢性萎缩性胃炎(Chronic Atrophic Gastritis,CAG)中常见的肠上皮化生、异型增生属于胃癌前状态。中医在逆转肠上皮化生及异型增生方面具有治疗优势。笔者系国医大师郭子光教授学术传承人,在郭师学术思想指导下,初步提出基于“人-症-病-证”体系慢性萎缩性胃炎临床辨治路径。以病为纲,抓住CAG“脾气胃阴亏虚,湿热瘀阻胃络”的共性核心病机;兼顾个性,结合患者不同证型的个性病机。以“益气养阴,清热燥湿,和胃通络”为基本治则,创制了“益胃复萎”方这一验方,基于此方,分型分期加减论治。病证结合,最大化地优化临床疗效,更能发挥中医特色优势。 展开更多
关键词 慢性萎缩性胃炎 --- 共性核心病机 病证结合 “益胃复萎”方
下载PDF
基于hACE2转导建立SARS-CoV-2 spike假病毒感染病证结合的小鼠病毒肺炎模型
9
作者 邱敏 陈欢 +2 位作者 江飞龙 朱青 刘莉 《中国中医急症》 2024年第9期1553-1556,1565,共5页
目的建立与评价一种安全、经济、有效的病证结合小鼠新冠病毒感染肺炎模型。方法30只KM种小鼠随机分为空白组、对照组及实验1组、实验2组、实验3组,每组各6只。每天把KM小鼠置于模拟寒湿环境中4 h,将表达hACE2的重组腺相关病毒(pAAV-hAC... 目的建立与评价一种安全、经济、有效的病证结合小鼠新冠病毒感染肺炎模型。方法30只KM种小鼠随机分为空白组、对照组及实验1组、实验2组、实验3组,每组各6只。每天把KM小鼠置于模拟寒湿环境中4 h,将表达hACE2的重组腺相关病毒(pAAV-hACE2)采用改良悬挂法气管内给药转导至肺组织,继以新型冠状病毒(SARS-CoV-2)spike假病毒采用相同的气管内给药方式造模。观察各组小鼠一般情况,检测体重变化、肺指数、血清炎性因子及肺部病理变化。结果免疫组化法显示h ACE2在小鼠肺组织中有效表达;在寒湿环境中给予SARS-CoV-2 spike假病毒后,实验组小鼠表现出类似疫毒犯肺证候的体征;且同样喂养条件和时间下,与空白组和对照组小鼠比较,实验组小鼠出现体重下降;实验1、2、3组小鼠出现肺指数显著增大(P<0.05或P<0.01),血清炎性因子白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)、白细胞介素-8(IL-8)、肿瘤坏死因子-α(TNF-α)显著升高(P<0.01),肺组织病理改变明显。结论本研究成功建立了一种安全、经济、有效的病证结合小鼠新冠病毒感染肺炎模型。 展开更多
关键词 新型冠状病毒(SARS-CoV-2)spike假病毒 重组腺相关病毒(pAAV-hACE2) 寒湿疫 病证结合 病毒 肺炎 小鼠动物模型
下载PDF
Clinical treatment of myasthenia gravis with deficiency of spleen and kidney based on combination of disease with syndrome theory 被引量:6
10
作者 Chao Jiang Ping Liu +3 位作者 Yan Liang Shaobo Qiu Wenjing Bao Jingsheng Zhang 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2013年第4期444-448,共5页
OBJECTIVE: To study the use of Jianjining in the treatment of myasthenia gravis (MG) patients with a deficiency of both spleen and kidney via the theory on the combination of disease with syndrome. METHODS: Sixty MG p... OBJECTIVE: To study the use of Jianjining in the treatment of myasthenia gravis (MG) patients with a deficiency of both spleen and kidney via the theory on the combination of disease with syndrome. METHODS: Sixty MG patients with a deficiency of both spleen and kidney were randomly divided into an treatment group (n=30) treated with Jianjining granules and Western Medicine (prednisone or pyridostigmine bromide) and a control group (n= 30) treated with Jianjining granules. The dosage of the three drugs was reduced over the course of treatment. After 3 and 6 months of treatment, the curative effect was evaluated with the muscle weakness severity scale (MWSS). RESULTS: The MWSS score after treatment declined significantly in both groups. The score in the treatment group was much lower than that in thecontrol group (P<0.05). The total effective rate was 63.33% (19/30) in the treatment group and 36.67% (11/30) in the control group after 3 months of treatment, and 80.00% (24/30) and 50.00% (15/30), respectively, after 6 months of treatment. The obvious and total effective rates in the treatment group were much higher than those in the control group (P<0.05). After 6 months of treatment, there were no obvious differences (P>0.05) in the obvious and effective rates between the 2 groups. However, the total effective rate in the treatment group was much higher than that in the control group (P<0.01). CONCLUSION: Using the theory on the combination of disease with syndrome, we found that the curative effect of Jianjining and Western Medicine on MG patients with deficiency of both spleen and kidney is worth further exploration. 展开更多
关键词 Myasthenia gravis Deficiency of spleen and kidney Jianjining combination of disease with syndrome
原文传递
中西医结合肿瘤“病-期-机-证-靶”诊疗新模式的构建
11
作者 王俊壹 李柳 程海波 《南京中医药大学学报》 CAS CSCD 北大核心 2024年第10期1136-1140,共5页
中医和西医是两种独立的医学体系和诊疗模式,在强调肿瘤综合治疗的现今,探索并构建一种中西医结合肿瘤诊疗新模式意义重大。传统中医治疗肿瘤重视整体观、治未病,具有整体调节机体、实现带瘤生存、预防复发转移等优势,但在现代医学背景... 中医和西医是两种独立的医学体系和诊疗模式,在强调肿瘤综合治疗的现今,探索并构建一种中西医结合肿瘤诊疗新模式意义重大。传统中医治疗肿瘤重视整体观、治未病,具有整体调节机体、实现带瘤生存、预防复发转移等优势,但在现代医学背景下,其面临诊断不明确、治疗不精准、疗效不确切、机制不清楚等难题。为了切实提高肿瘤治疗的临床疗效,该文基于传统中医的特色和优势,结合现代医学研究成果,提出“病-期-机-证-靶”的诊疗思路,初步构建中西医结合肿瘤诊疗新模式,以期实现中西医优势互补、协同增效。 展开更多
关键词 肿瘤 中西医结合 诊疗模式 辨病 辨期 辨机 辨证 辨靶
下载PDF
Assessment of Clinical Effect of Therapy Combining Disease with Syndrome on Rheumatoid Arthritis
12
作者 申洪波 白云静 +2 位作者 霍则军 李为农 唐先平 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2011年第1期39-43,共5页
Objective: To observe the effectiveness and safety of a therapy combining disease with syndrome on rheumatoid arthritis. Methods: Eighty patients with rheumatoid arthritis belonging to syndrome of damp-heat obstruct... Objective: To observe the effectiveness and safety of a therapy combining disease with syndrome on rheumatoid arthritis. Methods: Eighty patients with rheumatoid arthritis belonging to syndrome of damp-heat obstruction were randomly divided into a treatment group and a control group according to stratified blocked randomization method.Forty cases in the control group orally took Loxoprofen Sodium Tablet and Leifumite Tablet and the other 40 cases in the treatment group orally took a Chinese medicine for 12 weeks as a course of treatment. ACR therapeutic effect was used as the standard for evaluating the total therapeutic effect. Results: After l 2 weeks of treatment, there was a statistical difference (P〈0.01) in the improvement of VAS score, morning stiffness time, number of swelling joints, index of swelling joints, number of joints with tenderness, index of joints with tenderness, average grip strength of both hands, DSA28 score, HAQ, patient's assessment, physician's assessment, ESR, CRP and RF in both groups. The improvement of morning stiffness time, number of swelling joints, index of swelling joints, grip strength, HAQ and patient's assessment in the treatment group was much better than that in the control groups with statistical difference (P〈0.05). ACR20, ACR50 and ACR70 was 27.5% (11/40), 37.5% (15/40) and 22.5% (9/40) respectively in the treatment group and 40% (16/40), 27.5% (11/42) and 10.0% (4/40) respectively in the control group with statistical difference (P〈0.05) in the superiority of the treatment group over the control group. The incidence of adverse reaction in the control group was higher than that in the treatment group (P〈0.05). Conclusion: Definite therapeutic effect and high safety can be achieved in using the therapy combining disease with syndrome to treat rheumatoid arthritis belonging to syndrome of damp-heat obstruction. 展开更多
关键词 combination of disease with syndrome rheumatoid arthritis syndrome of damp-heat obstruction
原文传递
大黄黄连泻心汤、理中丸对消炎痛型胃溃疡寒热证模型大鼠血清IL-8和TNF-α含量的影响 被引量:21
13
作者 于海 柴剑波 +4 位作者 赵伟国 毕珺辉 蒋蕾 谢田 李冀 《时珍国医国药》 CAS CSCD 北大核心 2012年第2期382-383,共2页
目的通过观察大黄黄连泻心汤、理中丸对消炎痛型胃溃疡寒热证模型大鼠血清IL-8和TNF-α含量的影响,从炎症因子角度对该模型进行评价。方法采用寒热因素与消炎痛腹腔注射相结合,建立大鼠胃溃疡寒、热证动物模型,采用放射免疫法检测受试... 目的通过观察大黄黄连泻心汤、理中丸对消炎痛型胃溃疡寒热证模型大鼠血清IL-8和TNF-α含量的影响,从炎症因子角度对该模型进行评价。方法采用寒热因素与消炎痛腹腔注射相结合,建立大鼠胃溃疡寒、热证动物模型,采用放射免疫法检测受试大鼠血清中IL-8、TNF-α的含量。结果除单寒组TNF-α外,其他各模型组大鼠血清IL-8和TNF-α含量显著升高(P<0.05或P<0.01);大黄黄连泻心汤可显著降低热性溃疡组大鼠血清IL-8和TNF-α含量,理中丸可显著降低寒性溃疡组大鼠血清IL-8含量(P<0.05或P<0.01)。结论大黄黄连泻心汤、理中丸可通过降低IL-8和TNF-α含量,分别实现对热性和寒性模型大鼠胃粘膜的保护作用,是"方证相应"规律的体现,肯定了该实验所采用的胃溃疡"病证结合"造模方法确实可行。 展开更多
关键词 病证结合 方证相应 胃溃疡 寒热证 IL-8 TNF-Α
下载PDF
丹参酮ⅡA对高血压病血瘀证患者血清致伤ECV-304细胞活性的影响 被引量:7
14
作者 胡小勤 陈利国 +2 位作者 贾会欣 彭志允 张竞之 《辽宁中医杂志》 CAS 北大核心 2008年第7期964-966,共3页
目的:观察丹参酮ⅡA对高血压病血瘀证患者血清致伤ECV-304活性的影响。方法:将培养的人脐静脉内皮细胞株ECV-304按空白对照组、血瘀证组、TanⅡA40、20、10、5μg/mL组分组,MTT法检测ECV-304活性。结果:24h和48h血瘀组与空白对照组比较... 目的:观察丹参酮ⅡA对高血压病血瘀证患者血清致伤ECV-304活性的影响。方法:将培养的人脐静脉内皮细胞株ECV-304按空白对照组、血瘀证组、TanⅡA40、20、10、5μg/mL组分组,MTT法检测ECV-304活性。结果:24h和48h血瘀组与空白对照组比较,细胞活性显著降低(P<0.01);24h和48h TanⅡA 10μg/mL组与血瘀组比较,细胞活性显著增强(P<0.05,或P<0.01)。结论:高血压病血瘀证患者血清可以损伤内皮细胞,丹参酮ⅡA对内皮细胞具有保护作用。 展开更多
关键词 丹参酮ⅡA 血瘀证 ECV-304 病证结合
下载PDF
缺血性脑卒中痰热腑实证大鼠模型的建立与评价
15
作者 平兴枫 吕军影 +2 位作者 李凯 黄宗轩 尹建新 《中国组织工程研究》 CAS 北大核心 2025年第11期2301-2309,共9页
背景:中医药在治疗缺血性脑卒中痰热腑实证中具有丰富的经验和独特的优势,为深入挖掘中医药对该病的治疗靶点和治疗机制,建立稳定、可靠的缺血性脑卒中痰热腑实证病证结合动物模型是关键。目的:探讨缺血性脑卒中痰热腑实证大鼠模型的建... 背景:中医药在治疗缺血性脑卒中痰热腑实证中具有丰富的经验和独特的优势,为深入挖掘中医药对该病的治疗靶点和治疗机制,建立稳定、可靠的缺血性脑卒中痰热腑实证病证结合动物模型是关键。目的:探讨缺血性脑卒中痰热腑实证大鼠模型的建立方法及评价体系。方法:采用随机数字表法将60只SD大鼠随机分为4组:空白对照组(n=12)、缺血性脑卒中组(n=18)给予普通饲料喂养25 d,病证结合组(n=18)、痰热腑实证组(n=12)给予高脂饲料喂养25 d;第26天,空白对照组、缺血性脑卒中组灌胃给予生理盐水,病证结合组、痰热腑实证组灌胃给予自体粪便混悬液,连续灌胃3 d(灌胃期间继续给予高脂饲料);灌胃结束后,缺血性脑卒中组、病证结合组采用线栓法建立缺血性脑卒中模型,记录各组大鼠饮食量、饮水量、体质量、体温、粪便性状、鼻分泌物、喉中痰鸣、舌象等表征变化。造模结束后24 h,进行神经功能缺损评分、舌象表征、血脂水平检测、脑组织及颈动脉形态学观察以及血清胃动素和生长抑素水平检测。结果与结论:(1)与空白对照组比较,病证结合组大鼠呼吸急促、精神萎靡、烦躁、行动迟缓,鼻周可见大量分泌物、可闻及厚重的喉中痰鸣,饮食量、饮水量下降,体质量、体温及舌下脉络评分升高,粪便粒数、Bristol评分及粪便含水率降低;血清总胆固醇、三酰甘油、低密度脂蛋白胆固醇及生长抑素水平升高,胃动素水平降低,神经功能缺损评分升高,颈动脉发生显著病理改变,脑组织显示明显缺血形态学改变。缺血性脑卒中组仅能造成缺血性脑组织病理改变,不能复制出痰热腑实证的证候特征。痰热腑实证组能复制出典型的中医证候特征,但不能构建出缺血性脑卒中的脑组织病理改变。(2)结果表明,高脂诱导结合线栓法及自体粪便灌胃的多因素复合造模方法,可建立缺血性脑卒中痰热腑实证病证结合动物模型。 展开更多
关键词 缺血性脑卒中 痰热腑实证 病证结合 动物模型 症候因素
下载PDF
2019冠状病毒病(COVID-19)诊疗浙江经验 被引量:106
16
作者 徐凯进 蔡洪流 +14 位作者 沈毅弘 倪勤 陈瑜 胡少华 李剑平 王华芬 俞亮 黄河 裘云庆 魏国庆 方强 周建英 盛吉芳 梁廷波 李兰娟 《浙江大学学报(医学版)》 CAS CSCD 北大核心 2020年第2期147-157,共11页
当前2019冠状病毒病(COVID-19)疫情仍处于胶着状态。浙江大学医学院附属第一医院是国家感染性疾病临床医学中心,浙江省COVID-19患者救治中心。疫情一线的专家集智攻关,以国家卫生健康委员会和国家中医药管理局发布的COVID-19诊治指南为... 当前2019冠状病毒病(COVID-19)疫情仍处于胶着状态。浙江大学医学院附属第一医院是国家感染性疾病临床医学中心,浙江省COVID-19患者救治中心。疫情一线的专家集智攻关,以国家卫生健康委员会和国家中医药管理局发布的COVID-19诊治指南为依据,以抗病毒、抗休克、抗低氧血症、抗继发感染、维持水电解质和酸碱平衡、维持微生态平衡的“四抗二平衡”救治策略为核心,总结完善诊治方案,聚焦临床实践的一些具体问题,为COVID-19患者临床诊治提供借鉴。推荐以多学科协作诊治个性化治疗提高COVID-19患者救治质量。建议病原学检测、炎症指标监测和肺部影像学动态观察指导临床诊治。痰液的病毒核酸检测阳性率最高,约10%的急性期患者血液中检测到病毒核酸,50%的患者粪便中检测到病毒核酸,粪便中可分离出活病毒,须警惕粪便是否具有传染性;开展细胞因子等炎症指标监测有助于发现是否出现细胞因子风暴,判断是否需要人工肝血液净化治疗。通过以“四抗二平衡”为核心的综合治疗提高治愈率、降低病死率;早期抗病毒治疗能减少重症、危重症发生,前期使用阿比多尔联合洛匹那韦/利托那韦抗病毒显示出一定效果。休克和低氧血症多为细胞因子风暴所致,人工肝血液净化治疗能迅速清除炎症介质,阻断细胞因子风暴,对维持水电解质酸碱平衡也有很好的作用,可以提高危重型患者的疗效。重型病例疾病早期可适量、短程应用糖皮质激素。氧疗过程中,患者氧合指数小于200 mmHg时应及时转入重症医学科治疗;采用保守氧疗策略,不推荐常规进行无创通气;机械通气患者应严格执行集束化呼吸机相关性肺炎预防管理策略;氧合指数大于150 mmHg时,及早减、停镇静剂并撤机拔管。不推荐预防性使用抗菌药物,对于病程长,体温反复升高和血降钙素原水平升高的患者可酌情使用抗菌药物;要关注COVID-19患者继发真菌感染的诊治。COVID-19患者有肠道微生态紊乱,肠道乳酸杆菌、双歧杆菌等有益菌减少,推荐对所有患者进行营养和胃肠道功能评估,以营养支持和补充大剂量肠道微生态调节剂,纠正肠道微生态失衡,减少细菌移位和继发感染。COVID-19患者普遍存在焦虑和恐惧心理,应建立动态心理危机干预和处理。提倡中西医结合辨证施治;优化重型患者护理促进康复。严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染后病毒清除规律仍不明了,出院后仍须居家隔离2周,并定期随访。以上经验和建议在本中心实行,取得较好效果,但COVID-19是一种新的疾病,其诊治方案及策略仍有待进一步探索与完善。 展开更多
关键词 2019冠状病毒病 严重急性呼吸综合征冠状病毒2 新型冠状病毒感染 危重病 综合疗法 多学科诊疗
下载PDF
糖尿病肾病模型:动物模型、二维细胞模拟及三维类器官模型
17
作者 钱足平 陈勇 +2 位作者 冉燕 达静静 查艳 《中国组织工程研究》 CAS 北大核心 2025年第17期3632-3640,共9页
背景:近几年来,人类多能干细胞衍生的肾类器官及糖尿病肾病啮齿动物模型取得了一定的进展。然而,由于糖尿病肾病发病受环境因素及遗传因素共同作用,发病机制复杂,并且对于此类患者的临床治疗方法需要因人而异。因此,需要开发更灵活和综... 背景:近几年来,人类多能干细胞衍生的肾类器官及糖尿病肾病啮齿动物模型取得了一定的进展。然而,由于糖尿病肾病发病受环境因素及遗传因素共同作用,发病机制复杂,并且对于此类患者的临床治疗方法需要因人而异。因此,需要开发更灵活和综合的方法,从而发现强有力的临床前证据,以支持对糖尿病肾病患者进行更有针对性的干预。目的:从动物模型、二维细胞培养模拟及三维类器官模型等方面综述了糖尿病肾病模型的研究进展,为进一步的研究提供线索和思路。方法:以“糖尿病,糖尿病肾病,糖尿病肾病模型,糖尿病肾病动物模型,类器官,肾脏类器官,糖尿病肾病细胞模型,糖尿病肾病病证结合动物模型”为中文检索词,“Diabetes,diabetic nephropathy,diabetic kidney diseases,diabetic nephropathy models,diabetic nephropathy animal models,organoids,diabetic and organoids,diabetic and kidney organoids,kidney organoids,diabetic nephropathy cell models,diabetic nephropathy syndrome combined animal models”为英文检索词,检索中国知网及PubMed数据库,最终纳入101篇文献进行综述分析。结果与结论:糖尿病肾病体内模型和体外模型是深入研究糖尿病肾病发病机制的有力工具。动物模型可以观察到多系统之间的相互作用;二维细胞培养操作简便且成本较低;新兴的肾类器官填补了二维和整体水平之间的空白,无种属差异且一定程度模拟了人肾脏的复杂性。随着类器官技术的不断发展,肾类器官有望为探索糖尿病肾病的发病机制、病理生理过程和药物筛选提供一个新的视角。 展开更多
关键词 糖尿病肾病 肾脏类器官 糖尿病肾病类器官 细胞模型 动物模型 中医病证结合糖尿病肾病模型 工程化组织构建
下载PDF
蒙药秘诀红花-13味丸对偏头痛模型大鼠三叉神经核尾部c—fos蛋白表达及血浆中NO、NOS、Mg2+和ET的影响 被引量:1
18
作者 王高娃 金泉 《世界中医药》 CAS 2016年第B06期1595-1596,共2页
目的研究蒙药秘诀红花-13味油注射液造模。免疫组化SP法测定c-fos蛋白阳性表达强度(灰度值)。结果:正常对丸防治偏头痛的机理。方法:采用wister大鼠30只(雄性),随机分为五组:模型组、正常对照组和治疗组灌服0.39濒甲基纤维素... 目的研究蒙药秘诀红花-13味油注射液造模。免疫组化SP法测定c-fos蛋白阳性表达强度(灰度值)。结果:正常对丸防治偏头痛的机理。方法:采用wister大鼠30只(雄性),随机分为五组:模型组、正常对照组和治疗组灌服0.39濒甲基纤维素钠溶液,其余两组给予秘诀红花-13味丸(预防给原剂型组)和95%乙醇取秘诀红花-13药(预防给醇取药组)进行预防,1次/d,连续7d,第7天除正常组照组外其余四组颈部皮下注射硝酸甘照组比较模型组c-fos蛋白表达明显增多(P〈0.01);模型组大鼠三叉神经核尾部c—fos蛋白表达明显增多,与其他四组比较具有显著性差异(P〈O.01)。结论:蒙药秘诀红花-13味丸可以降低c-fos蛋白表达,从而阻止痛觉信息的传递,对偏头痛有预防和治疗作用。 展开更多
关键词 偏头痛 秘诀红花-13味 硝酸甘油 c—fos
下载PDF
阿尔茨海默病-痰瘀互结病证结合动物模型的建立与评价
19
作者 谭爱华 冉思邈 +1 位作者 石和元 杨硕 《中国比较医学杂志》 CAS 北大核心 2022年第4期39-46,共8页
目的本研究以探索建立一种可靠的阿尔茨海默病(Alzheimer’s disease,AD)与痰瘀互结证的病证结合动物模型为目的,为中医药防治AD提供相应的动物模型以及为建立病证结合动物模型的研究提供借鉴。方法以APP/PS1双转基因小鼠为AD模型动物,... 目的本研究以探索建立一种可靠的阿尔茨海默病(Alzheimer’s disease,AD)与痰瘀互结证的病证结合动物模型为目的,为中医药防治AD提供相应的动物模型以及为建立病证结合动物模型的研究提供借鉴。方法以APP/PS1双转基因小鼠为AD模型动物,并以冰水浴模拟“瘀”的病理状态;给予高脂饮食饲喂模拟“痰”的病理状态;二者结合以模拟“痰瘀互结”的病理状态。不同组小鼠给予不同的处理,分别建立AD-疾病模型组、AD-痰证组、AD-瘀证组、AD-痰瘀互结组。同系非转基因C57BL/6J小鼠为对照组。造模14 d后检测不同组小鼠的AD样行为学改变、舌象的客观变化、血液流变学和血脂改变,以及海马组织中相关蛋白含量的差异。结果造模14 d后,与对照组比较,AD各组小鼠行为学均存在明显改变、相关蛋白含量均升高。与AD-模型组比较,AD-各病理状态组小鼠舌色偏暗红、AD-瘀证组血液流变指标及AD-痰证组血脂指标均升高,其中AD-痰瘀互结组相关指标均显著升高。结论通过冰水浴联合高脂饮食饲喂处理APP/PS1双转基因小鼠14 d,可以成功建立AD-痰瘀互结证的病证结合动物模型,此方法建模成型率高、与临床症状相贴合,可为后续相关研究提供稳定的动物实验载体。 展开更多
关键词 阿尔茨海默病 痰瘀互结证 病证结合 动物模型
下载PDF
ND-EDS二联油乳疫苗免疫对比及田间免疫试验
20
作者 张安国 左颖 +2 位作者 孟庆鸿 张胜 李德学 《天津轻工业学院学报》 2000年第2期10-12,共3页
以自制 ND- EDS二联油苗为主进行免疫试验 ,并以同种二联油苗、ND和 EDS单油苗作对照 ,测定各种疫苗免疫后 ND、EDSHI抗体消涨规律 ,并进行强毒攻击试验。在此基础上 ,用自制二联苗实地免疫产前蛋鸡 2 6 830只 ,进行田间免疫试验。结果... 以自制 ND- EDS二联油苗为主进行免疫试验 ,并以同种二联油苗、ND和 EDS单油苗作对照 ,测定各种疫苗免疫后 ND、EDSHI抗体消涨规律 ,并进行强毒攻击试验。在此基础上 ,用自制二联苗实地免疫产前蛋鸡 2 6 830只 ,进行田间免疫试验。结果表明 :自制二联苗免疫效果良好 ,免疫期为 36 0 d左右 ,免疫期内对 ND和 EDS强毒攻击的保护率分别为 10 0 %和 95.8% 展开更多
关键词 ND EDS 二联油乳疫苗 田间免疫试验 蛋鸡
下载PDF
上一页 1 2 47 下一页 到第
使用帮助 返回顶部